On July 9, 2021, President Biden issued an executive order (EO) containing 72 directives to more than a dozen federal agencies, many of which have broad implications for healthcare. Specifically targeted are healthcare competition, hospital mergers,... Read More
Blogs & Articles | Healthcare | Healthcare Law | Hospitals and Healthcare Systems | In-house Counsel Legal Support Services | Life Sciences | Pharmaceutical Manufacturers | Pharmacy Law | Pharmacy Transactions | Physician Dispensing | Physicians and Medical Practices of all Specialties | Professional Practice Representation | Regulatory Compliance, including FDA, DEA and HIPAA

As the nation reels from the heartbreaking COVID-19 pandemic, scrutiny of Skilled Nursing Facilities and Long-Term Care facilities is all but certain to continue. Industry leaders and recent data suggests providers anticipate enhanced oversight from... Read More
Blogs & Articles | COVID-19 Resources | Healthcare | Healthcare Law | Healthcare Litigation | Healthcare Practice Compliance | Managed Care Negotiations and Strategies | Skilled Nursing Facilities and Long-Term | Value Based Care

On April 26, 2021 the Office of Inspector General (“OIG”) in the U.S. Department of Health and Human Services (“HHS”) issued a new Advisory Opinion Letter providing its analysis as to whether a “Proposed Arrangement” involving an... Read More
All types of single and multi-specialty medical practice groups | Ambulatory Care Facility Formation & Representation | Blogs & Articles | Healthcare | Healthcare Law | Healthcare Litigation | Healthcare Practice Compliance | Value Based Care

In a prior article, we addressed mandatory exclusions from federally funded health care programs for certain criminal convictions, and the importance of "thinking globally" while resolving a criminal investigation. Put another way, collateral... Read More
Blogs & Articles | Healthcare | Healthcare Law | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Defense and Government Investigation

Under the Section 340B federal discount drug program (340B program), pharmaceutical manufacturers enter into contracts with the Health & Human Services (HHS) in exchange for having their drugs covered by Medicaid and Medicare.  Pursuant to... Read More
Blogs & Articles | Life Sciences | Manufacturers | Pharmacy Law | Section 340B In-House and Contract Pharmacies

On March 18, 2021, the U.S. Senate confirmed Xavier Becerra, a longtime proponent of mental health parity laws, as the new Secretary of the Department of Health and Human Services (“HHS”). Becerra’s nomination was supported by Mental Health... Read More
All types of single and multi-specialty medical practice groups | Behavioral Health Practitioners | Blogs & Articles | Healthcare | Healthcare Law | Healthcare Litigation | Healthcare Practice Compliance

On January 21, 2021, the U.S. Department of Health and Human Services (“HHS”) published  proposed rules that would significantly modify existing regulations concerning the Health Insurance Portability and Accountability Act (“HIPAA”). The... Read More
All types of single and multi-specialty medical practice groups | Blogs & Articles | Healthcare | Healthcare Law | HIPAA Compliance

In November 2020, the U.S. Department of Health & Human Services, Office of Inspector General (the “OIG”) issued a Special Fraud Alert to highlight the fraud and abuse risks associated with pharmaceutical and medical device company speaker... Read More
Blogs & Articles | Professional Board Actions | Professional Practice Representation | White Collar Defense and Government Investigation